SCHEMBL29396463

SCHEMBL29396463

COc1cccc2oc(=O)ccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 6/20 1.00
▸ CYP3A4 P08684 3/20 0.60
▸ KDM4E B2RXH2 2/20 0.60
▸ ALDH1A1 P00352 2/20 0.60
▸ GLA P06280 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ HSD17B10 Q99714 1/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.60
▸ MAOA P21397 2/20 0.56
▸ KCNA3 P22001 1/20 0.55
▸ NPC1 O15118 2/20 0.54
▸ LMNA P02545 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ MCL1 Q07820 1/20 0.53
▸ CA12 O43570 2/20 0.51
▸ CA1 P00915 2/20 0.51
▸ CA2 P00918 2/20 0.51
▸ CA9 Q16790 2/20 0.51
▸ CNR2 P34972 1/20 0.50
▸ ALOX15 P16050 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1859616 1.00 CYP2A6 (1.00) CYP2A6CYP3A4KDM4EALDH1A1GLA
SCHEMBL15842646 0.82 CYP2A6 (0.70) CYP2A6CYP3A4KDM4EALDH1A1GLA
SCHEMBL15306019 0.82 CYP2A6 (0.72) CYP2A6CYP3A4KDM4EALDH1A1GLA
SCHEMBL16283608 0.81 CYP2A6 (0.68) CYP2A6CYP3A4KDM4EALDH1A1GLA
SCHEMBL11036109 0.81 CYP2A6 (1.00) CYP2A6CYP3A4KDM4EALDH1A1GLA
SCHEMBL15842640 0.81 CYP2A6 (0.68) CYP2A6CYP3A4KDM4EALDH1A1GLA
SCHEMBL16283607 0.80 CYP2A6 (0.66) CYP2A6CYP3A4KDM4EALDH1A1GLA
SCHEMBL1627582 0.78 CYP2A6 (0.64) CYP2A6CYP3A4KDM4EALDH1A1GLA
SCHEMBL15842925 0.77 KCNA3 (0.67) CYP2A6CYP3A4KDM4EALDH1A1GLA
SCHEMBL15842533 0.77 CYP2A6 (0.66) CYP2A6CYP3A4KDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230098166-A1 TWO-STEPS LIGHT AND HEAT CURABLE RESIN COMPOSITION UNIVERSITÉ DE HAUTE-ALSACE (FR) 2023-03-30 — — US disclosed
EP-4077497-A1 TWO-STEPS LIGHT AND HEAT CURABLE RESIN COMPOSITION Université de Haute-Alsace (FR) 2022-10-26 — — EP disclosed
WO-2022036040-A1 SYNTHESIS OF SMALL MOLECULES INSPIRED BY PHOMOXANTHONE A WORCESTER POLYTECHNIC INSTITUTE (US) 2022-02-17 — — WO disclosed
US-20220048879-A1 Synthesis of small molecules inspired by Phomoxanthone A WORCESTER POLYTECHNIC INSTITUTE 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048879-A1 Synthesis of small molecules inspired by Phomoxanthone A ERG28, SQLE, PHKA1 CYP2A6 208/4885CYP3A4 226/4885KDM4E 741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback